Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism

Table 1

Antiphospholipid profile at the time of presentation and at twelve-week follow-up.

Tests	At presentation (normal)	Three months after (normal)
Anticardiolipin IgG	140 (<15 GPL units)	135
Anticardiolipin IgM	30.4 (<12.5 MPL units)	60.6
Anti-β2 glycoprotein 1 IgG	>150 (<20 SGU)	>150
Anti-β2 glycoprotein 1 IgM	38 (<20 SMU)	42
PTT, lupus sensitive	82.5 (32–45 s)
DRVVT screen	69.1 (31.4–45 s)
DRVVT confirmation	1.6 (<1.3 s)
Hexagonal phase phospholipid	39.7 (0–8 s)